BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 11562742)

  • 1. Proteasome-mediated degradation of BRCA1 protein in MCF-7 human breast cancer cells.
    Choi YH
    Int J Oncol; 2001 Oct; 19(4):687-93. PubMed ID: 11562742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. F9 embryonal carcinoma cells fail to stop at G1/S boundary of the cell cycle after gamma-irradiation due to p21WAF1/CIP1 degradation.
    Malashicheva AB; Kislyakova TV; Aksenov ND; Osipov KA; Pospelov VA
    Oncogene; 2000 Aug; 19(34):3858-65. PubMed ID: 10951579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of proteasomes in T cell activation and proliferation.
    Wang X; Luo H; Chen H; Duguid W; Wu J
    J Immunol; 1998 Jan; 160(2):788-801. PubMed ID: 9551914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclin-dependent kinase activity is required for apoptotic death but not inclusion formation in cortical neurons after proteasomal inhibition.
    Rideout HJ; Wang Q; Park DS; Stefanis L
    J Neurosci; 2003 Feb; 23(4):1237-45. PubMed ID: 12598612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adhesion-regulated G1 cell cycle arrest in epithelial cells requires the downregulation of c-Myc.
    Benaud CM; Dickson RB
    Oncogene; 2001 Jul; 20(33):4554-67. PubMed ID: 11494151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth inhibition by CDK-cyclin and PCNA binding domains of p21 occurs by distinct mechanisms and is regulated by ubiquitin-proteasome pathway.
    Rousseau D; Cannella D; Boulaire J; Fitzgerald P; Fotedar A; Fotedar R
    Oncogene; 1999 Jul; 18(30):4313-25. PubMed ID: 10439039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct initiation and maintenance mechanisms cooperate to induce G1 cell cycle arrest in response to DNA damage.
    Agami R; Bernards R
    Cell; 2000 Jul; 102(1):55-66. PubMed ID: 10929713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyposmotic stress induces cell growth arrest via proteasome activation and cyclin/cyclin-dependent kinase degradation.
    Tao GZ; Rott LS; Lowe AW; Omary MB
    J Biol Chem; 2002 May; 277(22):19295-303. PubMed ID: 11897780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteasome inhibitors induce p53/p21-independent apoptosis in human glioma cells.
    Wagenknecht B; Hermisson M; Eitel K; Weller M
    Cell Physiol Biochem; 1999; 9(3):117-25. PubMed ID: 10494025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of proteasome function induced apoptosis in gastric cancer.
    Fan XM; Wong BC; Wang WP; Zhou XM; Cho CH; Yuen ST; Leung SY; Lin MC; Kung HF; Lam SK
    Int J Cancer; 2001 Aug; 93(4):481-8. PubMed ID: 11477551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IFNalpha 2b induces apoptosis and proteasome-mediated degradation of p27Kip1 in a human lung cancer cell line.
    Moro A; Perea SE; Pantoja C; Santos A; AraƱa MD; Serrano M
    Oncol Rep; 2001; 8(2):425-9. PubMed ID: 11182068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth inhibition by CDK-cyclin and PCNA binding domains of p21 occurs by distinct mechanisms and is regulated by ubiquitin-proteasome pathway.
    Rousseau D; Cannella D; Boulaire J; Fitzgerald P; Fotedar A; Fotedar R
    Oncogene; 1999 May; 18(21):3290-302. PubMed ID: 10359535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Turnover of cyclin E by the ubiquitin-proteasome pathway is regulated by cdk2 binding and cyclin phosphorylation.
    Clurman BE; Sheaff RJ; Thress K; Groudine M; Roberts JM
    Genes Dev; 1996 Aug; 10(16):1979-90. PubMed ID: 8769642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Helicobacter pylori increases proteasome-mediated degradation of p27(kip1) in gastric epithelial cells.
    Eguchi H; Herschenhous N; Kuzushita N; Moss SF
    Cancer Res; 2003 Aug; 63(15):4739-46. PubMed ID: 12907657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteasome-dependent degradation of cyclin D1 in 1-methyl-4-phenylpyridinium ion (MPP+)-induced cell cycle arrest.
    Bai J; Nakamura H; Ueda S; Kwon YW; Tanaka T; Ban S; Yodoi J
    J Biol Chem; 2004 Sep; 279(37):38710-4. PubMed ID: 15247282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo ubiquitination and proteasome-mediated degradation of p53(1).
    Maki CG; Huibregtse JM; Howley PM
    Cancer Res; 1996 Jun; 56(11):2649-54. PubMed ID: 8653711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pRb-related protein p130 is regulated by phosphorylation-dependent proteolysis via the protein-ubiquitin ligase SCF(Skp2).
    Tedesco D; Lukas J; Reed SI
    Genes Dev; 2002 Nov; 16(22):2946-57. PubMed ID: 12435635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lovastatin mediated G1 arrest in normal and tumor breast cells is through inhibition of CDK2 activity and redistribution of p21 and p27, independent of p53.
    Rao S; Lowe M; Herliczek TW; Keyomarsi K
    Oncogene; 1998 Nov; 17(18):2393-402. PubMed ID: 9811471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of BRCA1 by protein degradation.
    Blagosklonny MV; An WG; Melillo G; Nguyen P; Trepel JB; Neckers LM
    Oncogene; 1999 Nov; 18(47):6460-8. PubMed ID: 10597248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of p53 and p21Waf1 expression on G2/M phase arrest of colorectal carcinoma HCT116 cells to proteasome inhibitors.
    Kim OH; Lim JH; Woo KJ; Kim YH; Jin IN; Han ST; Park JW; Kwon TK
    Int J Oncol; 2004 Apr; 24(4):935-41. PubMed ID: 15010833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.